PREVIEW
As patients age, pharmacologic treatment of depression becomes more complicated because of the increased risk of drug interactions in the elderly. Choosing an appropriate agent requires a thorough knowledge of cytochrome P-450 enzymes, which affect drug metabolism in the liver. In this article, Dr Cadieux explains the critical factors affecting antidepressant treatment in elderly patients and discusses potential and documented drug interactions of selected agents.